Unlocking the body’s hidden healing potential
OrthoStim is led by an experienced board and management team with unmatched experience in stem cell, growth factor and bioelectric regeneration therapies dating back to the 1980’s. They have a successful track record of developing and commercializing new therapies that transform patients’ lives.
Pioneering Bioelectronic Medicine in the
treatment of joint disorders.
Bioelectronic medicine uses small micro implanted or bench top stimulation devices to deliver targeted electrical pulses directly to target tissue, muscle, cartilage tendon or bone to trigger stem cell homing, proliferation and differential, increase blood circulation and regeneration as well as managing inflammation via customized real time reading, modulation and management. It is designed (still under investigational use only not proven yet safe or effective with statistically significant controlled clinical trials) to provide ‘built-in’ therapy at a lower cost and is intended to improve safety compared with other stand alone device, drugs or biologic options. In advance disease states OrthoStim combines its bioelectric stimulation therapy with a re-fillable micro infusion pump for repeat delivers of it’s proprietary OS-15 fifteen component regeneration composition comprised of stem cells, growth factors, exosomes, micro RNAs, engineering nutrient hydrogel, amniotic fluid, PRF, selected alkaloids and matrix scaffolds.
OrthoStim intends to develop bioelectric and mixed stem cell based therapies as a breakthrough approach to treating joint degenerative and inflammatory diseases and conditions.